Sign up 3 colleagues for the price of 2 with the coupon code RCDVB!

Dear Colleague,

Come and join diabetes experts at GTC’s 7th Diabetes Drug Discovery and Development Conference on April 23-25, 2014 in Cambridge, MA and hear key thought-leader's opinions on the next block-buster drug target for T1DM and T2DM and discuss how FDA guidance affects approaches to developing new medications.

The conference is part of GTC's annual Diabetes Summit which includes two co-located conferences:
7th Diabetes Drug Discovery and Development
4th Diabetes Partnering and Deal-Making

GTC's Drug Discovery and Development conference will bring together the leading experts on diabetes from academia, government, small/medium size biotech, big pharma and healthcare organizations to discuss research on various novel targets, programs in developments, regulatory guidance and other relevant insights that can help guests advance their own research.

Below is the preliminary program. For further detailed information, follow the links below:
To view the 2014 detailed agenda, click here.
To view the 2014 speaker list, click here.

April 23, 2014
General Session
Joint sessions with Diabetes Summit and 2014 Stem Cell Summit
I. Cell Therapy and Diabetes - Stem Cell Research in the Diabetes Space

Conference I:
4th Diabetes Partnering and Deal-Making

Conference II:
7th Diabetes Drug Discovery and Development
April 24-25, 2014
General Session
Sethu Reddy, Cleveland Clinic
• Hans-Juergen Woerle, Vice President and Head of Therapeutic Area Metabolism, Boehringer Ingelheim
• Steven E. Nissen, Chairman of Cardiovascular Medicine, Cleveland Clinic Foundation

Panel Discussion: Type 1 Diabetes: "The New Honeymoon that Last Decades" - Clinical trial opportunities and the new diverse type 1 diabetic population - can we more accurately predict complications?
Denise Faustman, Harvard Medical School
Corinth Auld, Mercodia
Richard Oram, Exeter

Diabetes Partnering and Deal-Making
Diabetes Drug Discovery and Development
I. Innovative Partnering & Licensing Strategies
II. Partnering Opportunities in Diabetes Drug Development
III. Current Trends & Recent Deals
Panel Discussions:
I. Wining Strategies in Partnering & Deal-Making
II. Partnering with Non-Profits
III. Finding the Middle Ground in Big Pharma and Biotech Partnerships
IV. Partnering with Academia
V. Investment Opportunities in the Diabetes Space

For detailed agenda & participants click here

I. New Therapeutic Targets for Diabetes
II. Combination Therapy
III. Clinical Drug Development in Diabetes
IV. Advances in Obesity Drug Development

For detailed agenda & participants click here

The conference will run parallel with the 4th Diabetes Partnering and Deal Making conference.

Sign up for the summit pass to have access to both conferences of the summit. Or bring a team of 3 for the price of 2 by registering with the coupon code rcdvb!

We look forward to seeing you at the conference!

Best regards,

2014 Conference Advisory Committee

Keynote Speakers
Ralph A. DeFronzo
Professor of Medicine and Chief of the Diabetes Division University of Texas Health Science Center; Audie L. Murphy Memorial VA Hospital
Steven E. Nissen
Chairman of Cardiovascular Medicine
Cleveland Clinic Foundation
Prabhakar Viswanathan
Senior Medical Director, Diabetes & Metabolism
Takeda Pharmaceuticals
Hans-Juergen Woerle
Vice President Medicine Therapeutic Area Metabolism
Boehringer Ingelheim
"This conference was a very good opportunity to strengthen the connection between big pharma, biotech and academics, through a good mix between panel discussion, case studies, companies presentation and networking opportunity." - CEO, Poxel
"Excellent conference to engage with industry and academic collaborators and to learn about advances in technology in a setting that is very conducive to discussion and networking." - CEO, Joslin Diabetes Center
"The GTC Diabetes Summit converged stakeholders in discovery, translational development, commercialization and care delivery in a diabetes-focused conference that stimulated discussion, ideas, and networking so critical for advancing innovation to address the current global challenges. It was a high-value, engaging conference.” CEO, Exsulin
Attend ALL GTC Conferences for One Year for only $3,995 ($1,990 for Acad/Govt).
Click here to sign up!